Ledger.Open graph →

SEC Form D · filed February 25, 2025

Castle Creek Biosciences, Inc

Offering

$75.0M

Sold

$75.0M

Exemption

Rule 506(b)

Industry

Biotechnology

Location

Exton, PA

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (16)

Matthew J. Gantz · Exton, PAExec · Director Patrick J. Morris · Chicago, ILDirector Darien Parhad · Exton, PAExec Antonio Gracias · Seattle, WADirector Michael Parton · Grand Cayman, Cayman IslandsExec · Director David Brill · Exton, PADirector Matthew Crabtree · Exton, PADirector Jeffrey Aronin · Northbrook, ILDirector Jude Sullivan · Exton, PAExec Sharon R. Malka · Yavne, L3Exec · Director David Brill · Exton, PADirector Matthew Crabtree · Exton, PADirector Jeffrey Aronin · Parsippany, NJDirector Jude Sullivan · Exton, PAExec Darien Parhad · Exton, PAExec Antonio Gracias · San Carlos, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗